Progyny
PGNY
282 hedge funds and large institutions have $2.98B invested in Progyny in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 100 increasing their positions, 82 reducing their positions, and 16 closing their positions.
238% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 16
177% more call options, than puts
Call options by funds: $11.2M | Put options by funds: $4.05M
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
26% more capital invested
Capital invested by funds: $2.37B → $2.98B (+$607M)
22% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 82
15% more funds holding
Funds holding: 246 → 282 (+36)
1.4% less ownership
Funds ownership: 88.69% → 87.29% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$19.1M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$12.6M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$11.3M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$11.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$39.8M |
| 2 |
WI
Wafra Inc
New York
|
-$29.1M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$27.4M |
| 4 |
FAM
Fred Alger Management
New York
|
-$21M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$19.5M |
PGNY Hedge Fund Activity: Q3 2022 in Review
282 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Progyny (PGNY) for Q3 2022, worth a combined $2.98B — up 26% from $2.37B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new PGNY positions and 16 closed out — a net gain of 38 holders — while 100 added to existing stakes and 82 trimmed.
The largest buyer was OrbiMed, adding an estimated $19.1M. The largest seller was American Century Companies, cutting an estimated $39.8M.
- 282 institutional investors held Progyny (PGNY) as of Q3 2022, up from 246 in Q2 2022.
- Funds reported $2.98B of Progyny stock for Q3 2022, up 26% quarter-over-quarter.
- 54 funds opened new Progyny positions in Q3 2022 and 16 closed out, a net change of +38 holders.
- The largest Progyny buyer in Q3 2022 was OrbiMed, an estimated $19.1M added.
- The largest Progyny seller in Q3 2022 was American Century Companies, an estimated $39.8M sold.
Based on aggregated 13F filings for Q3 2022.